Theramed Corporation signs an eight year extension with EUSA Pharma Ltd. for the exclusive right to import, market and distribute COLLATAMP® G in Canada
Working to Save Lives and Limbs—New Hope Emerges For Canadians with Diabetic Foot Ulcers
Hospital-Acquired Infections in the News
Leading Canadian Hospitals Quick to Use New Implantable Antibiotic for Prevention and Treatment of Surgical Infections
New Website Educates Public on the Risks and Prevention of Deadly Surgical Infections
Economic Model Demonstrates Hospital Cost Savings Using Collatamp G
Ontario's Mandatory Public Reporting of Surgical Site Infections Puts SSIs on the Public's Radar
New Implantable Antibiotic Helps Canadian Hospitals Save Lives And Money By Preventing Surgical Infections
FDA Designates Gentamicin Surgical Implant (Collatamp G) as a Fast Track Development Program
Theramed Announces Long-Term Partnership with Canadian Society of Colon and Rectal Surgeons
Collatamp G in the Media
Collatamp G's current media exposure and advertising campaigns:
- (April, 2009) Collatamp G appears in feature-length profile of St. Thomas Elgin General Hospital
- (April, 2009) Collatamp G's advertisement in the Canadian Journal of Surgery
- (March, 2009, page 7) Collatamp G's current advertising campaign in Hospital News
- (Spring, 2009) Collatamp G's advertisement that appears in the print edition of the Canadian Orthopaedic Association Bulletin
